Related Experiment Videos
Recurrent very late stent thrombosis in a systemic lupus erythematous patient
Dong-Yob Lee1, Jong-Pil Park, Sung-Jun Ko
1Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea.
Insights
Systemic lupus erythematosus (SLE) patients undergoing coronary artery stenting face stent thrombosis risks. This case highlights the rare occurrence of very late recurrent stent thrombosis, happening four times in one SLE patient.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Coronary artery disease (CAD) is a primary cause of mortality in patients with systemic lupus erythematosus (SLE).
- Stent thrombosis is a known complication following percutaneous coronary intervention (PCI) in SLE patients, similar to the general population.
- Very late stent thrombosis (VLST) is an uncommon event, particularly recurrent instances.
Purpose of the Study:
- To report an extremely rare case of recurrent very late stent thrombosis (VLST) in a patient with systemic lupus erythematosus (SLE).
- To underscore the potential for severe thrombotic complications in SLE patients post-coronary stenting.
Main Methods:
- Case report detailing a patient with SLE who experienced multiple thrombotic events after coronary artery stenting.
- Review of clinical history, interventional procedures, and outcomes related to stent thrombosis.
Main Results:
- The patient, diagnosed with SLE, suffered four distinct episodes of very late stent thrombosis.
- This represents an exceptionally rare clinical presentation of recurrent VLST in the context of SLE and coronary stenting.
Conclusions:
- Patients with SLE may be at risk for recurrent and very late stent thrombosis, even after successful coronary stenting.
- This case emphasizes the need for vigilant monitoring and potentially tailored antithrombotic strategies in SLE patients with coronary artery disease.
Abstract:
Coronary artery disease is the most important cause of mortality in patients with systemic lupus erythematous (SLE). After stenting for coronary artery disease in SLE patients similar to non-SLE patients, the risk of stent thrombosis is always present. Although there are reports of stent thrombosis in SLE patients, very late recurrent stent thrombosis is rare. We experienced a case of very late recurrent stent thrombosis (4 times) in a patient with SLE.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management